Maximum likelihood estimation for nonembeddable Markov chains when the cycle length is shorter than the data observation interval
Duncan Ermini Leaf

TL;DR
This paper investigates the challenges of maximum likelihood estimation for Markov chains when data are collected at intervals longer than the chain's cycle length, highlighting issues with root extraction and non-convex optimization.
Contribution
It demonstrates the difficulty of estimating the transition matrix in such cases and explores local convergence issues through case studies, suggesting the need for alternative methods.
Findings
Maximum likelihood estimation becomes complex when data intervals exceed cycle length.
The $T$th root of the estimated transition matrix may not be valid or unique.
Global maximum likelihood estimates are hard to find as model complexity increases.
Abstract
Time-homogeneous Markov chains are often used as disease progression models in studies of cost-effectiveness and optimal decision-making. Maximum likelihood estimation of these models can be challenging when data are collected at a time interval longer than the model's transition cycle length. For example, it may be necessary to estimate a monthly transition model from data collected annually. The likelihood for a time-homogeneous Markov chain with transition matrix and data observed at intervals of cycles is a function of The maximum likelihood estimate of is easily obtained from the data. The th root of this estimate would then be a maximum likelihood estimate for However, the th root of is not necessarily a valid transition matrix. Maximum likelihood estimation of is a constrained…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Statistical Methods and Bayesian Inference · Health Systems, Economic Evaluations, Quality of Life
